FDC Ltd Q2 Profit Climbs to Rs 49.06 Crore, Announces Buyback

FDC Ltd reported a consolidated profit of Rs 49.06 crore for the quarter ended September 30, 2026, marking a significant increase from Rs 28.37 crore in the same period last year. Revenue from operations also grew to Rs 572.14 crore, compared to Rs 473.03 crore reported in the corresponding period of the previous fiscal year.

Reader Takeaway: Strong profit growth and a Rs 120 crore share buyback signal capital return, though investors must track tender timelines.

What Just Happened

FDC Ltd’s Board of Directors has approved a share buyback of up to 24,00,000 equity shares at a price of Rs 500 per share. The total outlay for this buyback is capped at Rs 120 crore, representing 1.47% of the total paid-up equity capital of the company. The buyback will be executed via the tender offer route, with the record date set for November 13, 2026.

Why This Matters

The buyback serves as a direct mechanism to return capital to shareholders while the jump in net profit reflects improved operational performance. The company’s total income for the quarter stood at Rs 590.08 crore, supported by robust pharmaceutical sales and a net fair value gain of Rs 16.08 crore recorded under other income as per Ind AS 109.

What Changes Now

Shareholders should prepare for the public announcement regarding the tender offer timelines. The earnings per share (EPS) for the quarter rose to Rs 3.01, up from Rs 1.75 in the year-ago period. Investors should note that the fair value gains recorded this quarter may fluctuate in future filings depending on market conditions, as noted by the company.

What to Track Next

Investors should monitor the official public announcement for the detailed process, opening and closing dates for the tender offer, and further instructions on how eligible shareholders can participate in the buyback.